Institutional investors purchased a net $6.4 million shares of BIOS during the quarter ended March 2017 and now own 86.56% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Managed Health Care industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VENOR CAPITAL MANAGEMENT LP Bought 12.0 Million shares of BioScrip Inc
GILDER, GAGNON, HOWE & CO. LLC Bought 4.4 Million shares of BioScrip Inc
FIAM LLC Bought 1.3 Million shares of BioScrip Inc